Without a doubt LPI goes above $200 if Oil goes to $175 like Hurricane Dimon says.........Have a Great Weekend everyone. I Know I will!
I
Swedish Orphan Biovitrum : Advent and Aurora Investment offers to buy Sweden's SOBI in $8- bln deal
STOCKHOLM, Sept 2 (Reuters) - U.S. venture capital firm Advent International and Aurora Investment, an affiliate of capital market firm GIC, has offered to buy Swedish Orphan Biovitrum (SOBI) in a deal valuing it at about 69.4 billion Swedish crowns ($8 billion).
SOBI said the two firms had offered 235 Swedish crowns ($27.3) for each share through Agnafit Bidco AB.
Investors AB and Fjärde AP-Fonden, with SOBI stakes of about 36.45% and 6.96% respectively, have separately agreed to accept the offer, the company said, adding that its board had unanimously recommended that shareholders accept.
SOBI said the offer price was a premium of about 34.5% to its Aug. 25 closing price of 174.70 crowns on Nasdaq Stockholm.
"The board believes that the terms of the offer recognise SOBI’s long-term growth prospects, as well as the risks associated with those prospects, and provide certainty, in cash, to shareholders," it said. ($1=8.6178 Swedish crowns) (Reporting by Helena Soderpalm; Editing by Clarence Fernandez)
STOCKHOLM , Dec. 9, 2019 /PRNewswire/ -- Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™),.
STOCKHOLM , Dec. 9, 2019 /PRNewswire/ -- Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™),.
marketwirenews.com
b
What just happened?
M
strong upwards trend
I
By the way, you can buy Stock under ticker "SOBI" at ETORO trading.
I
Luckily I sold alll my SOBI stock immediately after takeover was announced. Don't know why but had a feeling it wasn't going through. That said, nothing has changed as regards the Company and I wll get back on shortly I think. Have to see how their Covid therapy drug goes.
P
I get their Zaditen for asthma and Mast Cell Activation disorder - purchased via North Drug Store in Canada. The product is excellent - it works.
STOCKHOLM, Sept 2 (Reuters) - U.S. venture capital firm Advent International and Aurora Investment, an affiliate of capital market firm GIC, has offered to buy Swedish Orphan Biovitrum (SOBI) in a deal valuing it at about 69.4 billion Swedish crowns ($8 billion).
SOBI said the two firms had offered 235 Swedish crowns ($27.3) for each share through Agnafit Bidco AB.
Investors AB and Fjärde AP-Fonden, with SOBI stakes of about 36.45% and 6.96% respectively, have separately agreed to accept the offer, the company said, adding that its board had unanimously recommended that shareholders accept.
SOBI said the offer price was a premium of about 34.5% to its Aug. 25 closing price of 174.70 crowns on Nasdaq Stockholm.
"The board believes that the terms of the offer recognise SOBI’s long-term growth prospects, as well as the risks associated with those prospects, and provide certainty, in cash, to shareholders," it said. ($1=8.6178 Swedish crowns) (Reporting by Helena Soderpalm; Editing by Clarence Fernandez)
excellent - it works.